{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T05:31:54Z","timestamp":1740807114622,"version":"3.38.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,28]]},"DOI":"10.7759\/cureus.79818","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T12:59:33Z","timestamp":1740747573000},"source":"Crossref","is-referenced-by-count":0,"title":["Successful Transition From Topical Ophthalmic Drops to Cream Formulation in the Management of Mild Allergic Conjunctivitis: A Case Report"],"prefix":"10.7759","author":[{"given":"Mai","family":"Nishio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eisuke","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Asai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumi","family":"Fukagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Fujishima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s10384-024-01108-9","article-title":"Safety and efficacy of a novel 0.5% epinastine topical eyelid cream in allergic conjunctivitis: a phase 3 trial","volume":"68","author":"Fujishima H","year":"2024","unstructured":"Fujishima H, Shoji J. Safety and efficacy of a novel 0.5% epinastine topical eyelid cream in allergic conjunctivitis: a phase 3 trial. Jpn J Ophthalmol. 2024, 68:651-9. 10.1007\/s10384-024-01108-9","journal-title":"Jpn J Ophthalmol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2004.10.042","article-title":"Allergic conjunctivitis: update on pathophysiology and prospects for future treatment","volume":"115","author":"Ono SJ","year":"2005","unstructured":"Ono SJ, Abelson MB. Allergic conjunctivitis: update on pathophysiology and prospects for future treatment. J Allergy Clin Immunol. 2005, 115:118-22. 10.1016\/j.jaci.2004.10.042","journal-title":"J Allergy Clin Immunol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1177\/2040622315612745","article-title":"Ocular itch associated with allergic conjunctivitis: latest evidence and clinical management","volume":"7","author":"Ackerman S","year":"2016","unstructured":"Ackerman S, Smith LM, Gomes PJ. Ocular itch associated with allergic conjunctivitis: latest evidence and clinical management. Ther Adv Chronic Dis. 2016, 7:52-67. 10.1177\/2040622315612745","journal-title":"Ther Adv Chronic Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/6917185","article-title":"The role of Th17 cells and IL-17 in Th2 immune responses of allergic conjunctivitis","volume":"2020","author":"Meng XT","year":"2020","unstructured":"Meng XT, Shi YY, Zhang H, Zhou HY. The role of Th17 cells and IL-17 in Th2 immune responses of allergic conjunctivitis. J Ophthalmol. 2020, 2020:6917185. 10.1155\/2020\/6917185","journal-title":"J Ophthalmol"},{"key":"ref5","article-title":"Topical treatments for seasonal allergic conjunctivitis: systematic review and meta-analysis of efficacy and effectiveness","volume":"503","author":"Owen CG","year":"2004","unstructured":"Owen CG, Shah A, Henshaw K, Smeeth L, Sheikh A. Topical treatments for seasonal allergic conjunctivitis: systematic review and meta-analysis of efficacy and effectiveness. Br J Gen Pract. 2004, 503:451-6.","journal-title":"Br J Gen Pract"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2174\/187221311794474883","article-title":"Recent patents and emerging therapeutics in the treatment of allergic conjunctivitis","volume":"5","author":"Mishra GP","year":"2011","unstructured":"Mishra GP, Tamboli V, Jwala J, Mitra AK. Recent patents and emerging therapeutics in the treatment of allergic conjunctivitis. Recent Pat Inflamm Allergy Drug Discov. 2011, 5:26-36. 10.2174\/187221311794474883","journal-title":"Recent Pat Inflamm Allergy Drug Discov"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009566.","article-title":"Topical antihistamines and mast cell stabilisers for treating seasonal and perennial allergic conjunctivitis","volume":"1","author":"Castillo M","year":"2015","unstructured":"Castillo M, Scott NW, Mustafa MZ, Mustafa MS, Azuara-Blanco A. Topical antihistamines and mast cell stabilisers for treating seasonal and perennial allergic conjunctivitis. Cochrane Database Syst Rev. 2015, 1:009566. 10.1002\/14651858.CD009566.","journal-title":"Cochrane Database Syst Rev"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s13223-021-00513-w","article-title":"Long-term outcomes of 0.1% tacrolimus eye drops in eyes with severe allergic conjunctival diseases","volume":"17","author":"Yazu H","year":"2021","unstructured":"Yazu H, Fukagawa K, Shimizu E, Sato Y, Fujishima H. Long-term outcomes of 0.1% tacrolimus eye drops in eyes with severe allergic conjunctival diseases. Allergy Asthma Clin Immunol. 2021, 17:11. 10.1186\/s13223-021-00513-w","journal-title":"Allergy Asthma Clin Immunol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-67117-3","article-title":"JACQLQ subjective symptom questionnaire score and clinical test results for patients with allergic conjunctival disease","volume":"14","author":"Yamana Y","year":"2024","unstructured":"Yamana Y, Yamana S, Uchio E. JACQLQ subjective symptom questionnaire score and clinical test results for patients with allergic conjunctival disease. Sci Rep. 2024, 14:16235. 10.1038\/s41598-024-67117-3","journal-title":"Sci Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.alit.2020.03.005","article-title":"Japanese guidelines for allergic conjunctival diseases 2020","volume":"69","author":"Miyazaki D","year":"2020","unstructured":"Miyazaki D, Takamura E, Uchio E, et al.. Japanese guidelines for allergic conjunctival diseases 2020. Allergol Int. 2020, 69:346-55. 10.1016\/j.alit.2020.03.005","journal-title":"Allergol Int"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0215130","article-title":"\"Smart Eye Camera\": an innovative technique to evaluate tear film breakup time in a murine dry eye disease model","volume":"14","author":"Shimizu E","year":"2019","unstructured":"Shimizu E, Ogawa Y, Yazu H, et al.. \"Smart Eye Camera\": an innovative technique to evaluate tear film breakup time in a murine dry eye disease model. PLoS One. 2019, 14:e0215130. 10.1371\/journal.pone.0215130","journal-title":"PLoS One"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.10.4.28","article-title":"Smart eye camera: a validation study for evaluating the tear film breakup time in human subjects","volume":"10","author":"Shimizu E","year":"2021","unstructured":"Shimizu E, Yazu H, Aketa N, et al.. Smart eye camera: a validation study for evaluating the tear film breakup time in human subjects. Transl Vis Sci Technol. 2021, 10:28. 10.1167\/tvst.10.4.28","journal-title":"Transl Vis Sci Technol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4103\/IJO.IJO_292_23","article-title":"A study establishing sensitivity and accuracy of smartphone photography in ophthalmologic community outreach programs: review of a smart eye camera","volume":"71","author":"Andhare P","year":"2023","unstructured":"Andhare P, Ramasamy K, Ramesh R, Shimizu E, Nakayama S, Gandhi P. A study establishing sensitivity and accuracy of smartphone photography in ophthalmologic community outreach programs: review of a smart eye camera. Indian J Ophthalmol. 2023, 71:2416-20. 10.4103\/IJO.IJO_292_23","journal-title":"Indian J Ophthalmol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2023.0132","article-title":"Epinastine cream: a novel once-daily therapeutic agent for allergic conjunctivitis","volume":"40","author":"Ogura N","year":"2024","unstructured":"Ogura N, Fujisawa K, Kato M. Epinastine cream: a novel once-daily therapeutic agent for allergic conjunctivitis. J Ocul Pharmacol Ther. 2024, 40:173-80. 10.1089\/jop.2023.0132","journal-title":"J Ocul Pharmacol Ther"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s10384-024-01070-6","article-title":"Trans-eyelid distribution of epinastine to the conjunctiva following eyelid application in rabbits","volume":"68","author":"Mochizuki T","year":"2024","unstructured":"Mochizuki T, Hata T, Mori N, Yamazaki T, Noto T, Mano H. Trans-eyelid distribution of epinastine to the conjunctiva following eyelid application in rabbits. Jpn J Ophthalmol. 2024, 68:594-602. 10.1007\/s10384-024-01070-6","journal-title":"Jpn J Ophthalmol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S264926","article-title":"Improving adherence to topical medication in patients with glaucoma","volume":"15","author":"Tapply I","year":"2021","unstructured":"Tapply I, Broadway DC. Improving adherence to topical medication in patients with glaucoma. Patient Prefer Adherence. 2021, 15:1477-89. 10.2147\/PPA.S264926","journal-title":"Patient Prefer Adherence"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.74268","article-title":"Efficacy of Epinastine eyelid cream in pediatric vernal keratoconjunctivitis: a case report","volume":"16","author":"Hashida N","year":"2024","unstructured":"Hashida N, Hirose R, Shiozaki D, Mamoto Y. Efficacy of Epinastine eyelid cream in pediatric vernal keratoconjunctivitis: a case report. Cureus. 2024, 16:e74268. 10.7759\/cureus.74268","journal-title":"Cureus"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmedinf.2023.105226","article-title":"Impact of Kayumidas\u00a9 app on subjective symptoms and treatment adherence in allergic rhinoconjunctivitis: prospective single-arm interventional pilot study","volume":"179","author":"Mimura T","year":"2023","unstructured":"Mimura T, Iwasaki M, Fukagawa K. Impact of Kayumidas\u00a9 app on subjective symptoms and treatment adherence in allergic rhinoconjunctivitis: prospective single-arm interventional pilot study. Int J Med Inform. 2023, 179:105226. 10.1016\/j.ijmedinf.2023.105226","journal-title":"Int J Med Inform"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/331927-successful-transition-from-topical-ophthalmic-drops-to-cream-formulation-in-the-management-of-mild-allergic-conjunctivitis-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T12:59:35Z","timestamp":1740747575000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/331927-successful-transition-from-topical-ophthalmic-drops-to-cream-formulation-in-the-management-of-mild-allergic-conjunctivitis-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.79818","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,28]]}}}